Skip to Main Content

Author Details

Cindy Q Yao
Ontario Institute for Cancer Research
2011
29
17
PMIDPaper TitleJournal TitlePublished Year
34238931Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.NPJ Breast Cancer2021
33549463Comparing the Ability of Physician-Reported Versus Patient-Reported Performance Status to Predict Survival in a Population-Based Cohort of Newly Diagnosed Cancer Patients.Clin Oncol (R Coll Radiol)2021
31161221Temporal Stability and Prognostic Biomarker Potential of the Prostate Cancer Urine miRNA Transcriptome.J Natl Cancer Inst2020
32881987Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.PLoS One2020
30643250Molecular landmarks of tumor hypoxia across cancer types.Nat Genet2019
35100692Identification of Distinct Prognostic Groups: Implications for Patient Selection to Targeted Therapies Among Anti-Endocrine Therapy-Resistant Early Breast Cancers.JCO Precis Oncol2019
313866712,3,7,8-Tetrachlorodibenzo-p-dioxin modifies alternative splicing in mouse liver.PLoS One2019
31511937Comparative toxicoproteogenomics of mouse and rat liver identifies TCDD-resistance genes.Arch Toxicol2019
31591588Genome-wide germline correlates of the epigenetic landscape of prostate cancer.Nat Med2019
30889379The Proteogenomic Landscape of Curable Prostate Cancer.Cancer Cell2019
30665349BPG: Seamless, automated and interactive visualization of scientific data.BMC Bioinformatics2019
29112706NanoStringNormCNV: pre-processing of NanoString CNV data.Bioinformatics2018
30033362Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.Cell2018
30420699Pathway-based subnetworks enable cross-disease biomarker discovery.Nat Commun2018
29618387Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer.J Ovarian Res2018
27815082Translating a Prognostic DNA Genomic Classifier into the Clinic: Retrospective Validation in 563 Localized Prostate Tumors.Eur Urol2017
28086803Compendium of TCDD-mediated transcriptomic response datasets in mammalian model systems.BMC Genomics2017
28649643Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.NPJ Breast Cancer2017
27056899A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.Oncotarget2016
27526323Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.Nat Genet2016
27350604Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.Nat Commun2016
26852132Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.Breast Cancer Res2016
25314936The transcriptomic profile of ovarian cancer grading.Cancer Med2015
25351418Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.Nat Commun2014
25456371Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.Lancet Oncol2014
25312014Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.BMC Cancer2014
22342509Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).Toxicol Appl Pharmacol2012
22986220Identification of differentially expressed proteins in direct expressed prostatic secretions of men with organ-confined versus extracapsular prostate cancer.Mol Cell Proteomics2012
21215274Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity.Toxicol Appl Pharmacol2011
  • 1 - 29 of 29

Recommended Authors

Camila M Lopes-Ramos
Harvard T. H. Chan School of Public Health
Career Start Year 2012
Number of shared co-authors 0
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Career Start Year 2011
Number of shared co-authors 3
Mandeep Takhar
GenomeDx Biosciences Inc.
Career Start Year 2010
Number of shared co-authors 26
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 10
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 24
Ying-Wooi Wan
Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Stephen R Piccolo
Brigham Young University
Career Start Year 2008
Number of shared co-authors 5
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 1
Svitlana Tyekucheva
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 6
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 17
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 0
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 1
Nathalie Pochet
Broad Institute of MIT and Harvard
Career Start Year 2004
Number of shared co-authors 0
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 40
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 15
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 5
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
George C Tseng
University of Pittsburgh School of Public Health
Career Start Year 2001
Number of shared co-authors 0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 15
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 11
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Career Start Year 1996
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 1
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 30
Keith A Baggerly
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 7
Kevin R Coombes
Medical College of Georgia
Career Start Year 1990
Number of shared co-authors 2
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 4

Collaborators

Paul C Boutros
University of California los angeles
Co-authored papers 27
John M S Bartlett
University of Edinburgh
Co-authored papers 9
Robert G Bristow
University of Toronto
Co-authored papers 8
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 7
John D Watson
Ontario Institute for Cancer Research
Co-authored papers 6
Stephenie D Prokopec
University Health Network
Co-authored papers 6
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 6
Syed Haider
Institute of Cancer Research
Co-authored papers 6
Melanie Spears
Ontario Institute for Cancer Research
Co-authored papers 5
Raimo Pohjanvirta
Department of Food Hygiene and Environmental Health, University of Helsinki
Co-authored papers 5
Emilie Lalonde
University of Pennsylvania
Co-authored papers 5
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 4
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers 4
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 4
Christine P'ng
Ontario Institute for Cancer Research
Co-authored papers 4
Allan B Okey
University of Toronto
Co-authored papers 4
Nicola Lyttle
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 4
Julie Livingstone
University of California los angeles
Co-authored papers 4
Nicholas J Harding
Big Data Institute, University of Oxford
Co-authored papers 4
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 4
Dorota H Sendorek
Ontario Institute for Cancer Research
Co-authored papers 4
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 4
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers 4
Lauren C Chong
University of British Columbia
Co-authored papers 4
Christos Markopoulos
National and Kapodistrian University of Athens
Co-authored papers 3
Luc Dirix
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Co-authored papers 3
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 3
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers 3
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 3
Nathalie C Moon
Ontario Institute for Cancer Research
Co-authored papers 3
Release 1.2